IsoPairFinder: A Computational Workflow for Prioritizing LC–MS Feature Pairs Representing Candidate Microbial Pathway Intermediates from Stable Isotope Tracing Metabolomics
Journal of the American Society for Mass Spectrometry · 04.11.2026 · 37 (11) · 2968-2972
DOI: 10.1021/jasms.6c00253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, online erschienen am 08.10.2026. Verfasst von Zhiwei Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University School of Medicine, Stanford, California94305, United States. Hauptthemen laut MEDLINE: Metabolomics, Liquid Chromatography-Mass Spectrometry, Software. Die Arbeit nennt 21 Literaturangaben. Gefördert von: NIH HHS, NCCIH NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Functional annotation of microbial genes lags behind the pace of genome sequencing, leaving major gaps in our understanding of microbial metabolism. Combining genetic perturbation with untargeted stable isotope tracing metabolomics provides a powerful strategy for identifying pathway intermediates and elucidating microbial metabolic pathways. To streamline this workflow, we developed IsoPairFinder, a computational tool that prioritizes pathway-intermediate feature pairs by analyzing paired unlabeled (12C) and 13C-labeled metabolomics datasets from genetically perturbed microbes. By consolidating redundant liquid chromatography–mass spectrometry (LC–MS) features and pairing features across unlabeled and labeled samples, IsoPairFinder reduces candidate lists to plausible isotope-paired intermediates for downstream validation. We demonstrate the utility of IsoPairFinder in a case study of uric acid catabolism in Clostridium sporogenes, where it filters redundant features and prioritizes LC–MS feature pairs representing gene-associated pathway intermediates. IsoPairFinder is available as an open-source R package and as a web-based workflow within GNPS2. By integrating differential analysis and isotope-pair detection into a single workflow, IsoPairFinder enables microbiologists to connect metabolomic features with microbial gene function more efficiently, thereby accelerating microbial pathway discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Stanford University School of Medicine, Stanford, California94305, United States.
- Department of Computer Science and Engineering, University of California Riverside, Riverside, California92521, United States.
- Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California94305, United States.
ORCID-Profile: Zhiwei Zhou, Dylan Dodd
Förderung
- NIH HHS
- NCCIH NIH HHS
- NIDDK NIH HHS
- Stanford University
- NIGMS NIH HHS
- Stanford Medicine Children's Health Center for IBD and Celiac Disease
- Stanford Microbiome Therapies Initiative
- National Institutes of Health
Zitieren
APA
Zhou, Z., Liu, Y., Wang, M., & Dodd, D. (2026). IsoPairFinder: A Computational Workflow for Prioritizing LC–MS Feature Pairs Representing Candidate Microbial Pathway Intermediates from Stable Isotope Tracing Metabolomics. Journal of the American Society for Mass Spectrometry, 37(11), 2968-2972. https://doi.org/10.1021/jasms.6c00253
Vancouver
Zhou Z, Liu Y, Wang M, Dodd D. IsoPairFinder: A Computational Workflow for Prioritizing LC–MS Feature Pairs Representing Candidate Microbial Pathway Intermediates from Stable Isotope Tracing Metabolomics. Journal of the American Society for Mass Spectrometry. 2026;37(11):2968-2972. doi:10.1021/jasms.6c00253
BibTeX
@article{Zhou2026,
author = {Zhou, Zhiwei and Liu, Yuanyuan and Wang, Mingxun and Dodd, Dylan},
title = {IsoPairFinder: A Computational Workflow for Prioritizing LC–MS Feature Pairs Representing Candidate Microbial Pathway Intermediates from Stable Isotope Tracing Metabolomics},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2026},
volume = {37},
number = {11},
pages = {2968--2972},
doi = {10.1021/jasms.6c00253}
}
EUVIMED